4/A

FORM 4/A SUBMISSION

Company: Olema Pharmaceuticals, Inc.
Filed: November 20, 2020
Period of Report: June 15, 2020
Accession Number: 0001209191-20-059759

View Document ↗ View on SEC.gov ↗